- Company name
- TOWA PHARMACEUTICAL CO., LTD.
- Headquarters
- 2-11, Shinbashi-cho, Kadoma, Osaka 571-8580
JAPAN TEL:+81(0)6-6900-9100
FAX:+81(0)6-6908-2138
- President
- Itsuro YOSHIDA
- Established
- June 1951
- Incorporated
- April 1957
- Listing
- Prime section of the Tokyo Stock Exchange（TSE）
(Securities code :4553)
- Capital stock
- 4,717 million yen (as of end of March 2023)
- Business operations
- Manufacture and sale of ethical drugs
- Products
- 780 (as of December 2023)
- Employees
- 3,519 (as of April 1st, 2024)
- Subsidiary company
- J-DOLPH Pharmaceutical CO., LTD.
(Manufacture and sale of ethical drugs)
Daichi Kasei CO., LTD.
(R&D and production of active pharmaceutical ingredients and intermediates)
Greencaps Pharmaceutical CO., LTD.
(Production of ethical drugs of softcapsules)
T Square Solutions CO., LTD.
(Delivery and relevant business of IT service associated with healthcare)
Towa Pharma International Holdings, S.L.
(EU/US Regional Headquarters)
Protosera Inc.
(Disease risk testing service business and research and development support business)
Sunsho Pharmaceutical Co., Ltd.
(Planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods and other miscellaneous merchandizes)
KAMATA CO., LTD.
(Contract manufacturer of health food products)
Kyushu Iyaku CO., LTD.
(Sale of ethical drugs and quasi drugs)
